These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28464333)

  • 1. Pharmacokinetic and pharmacodynamic integration and modeling of acetylkitasamycin in swine for Clostridium perfringens.
    Nan J; Hao H; Xie S; Pan Y; Xi C; Mao F; Liu Z; Huang L; Yuan Z
    J Vet Pharmacol Ther; 2017 Dec; 40(6):641-655. PubMed ID: 28464333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial activity of cyadox against Clostridium perfringens in broilers and a dosage regimen design based on pharmacokinetic-pharmacodynamic modeling.
    Wang F; Mi K; Ahmad I; Xie S; Hussain HI; Yuan Z; Dai M; Huang L
    Microb Pathog; 2020 Apr; 141():103981. PubMed ID: 31962185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and pharmacodynamic modeling of cyadox against Clostridium perfringens in swine.
    Yan L; Xie S; Chen D; Pan Y; Tao Y; Qu W; Liu Z; Yuan Z; Huang L
    Sci Rep; 2017 Jun; 7(1):4064. PubMed ID: 28642571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic-pharmacodynamic modeling of tylosin against Streptococcus suis in pigs.
    Huang L; Zhang H; Li M; Ahmad I; Wang Y; Yuan Z
    BMC Vet Res; 2018 Oct; 14(1):319. PubMed ID: 30355326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PK-PD Modeling and Optimal Dosing Regimen of Acetylkitasamycin against
    Huang A; Mao F; Huang L; Xie S; Pan Y; Qu W; Cheng G; Liu Z; Yuan Z; Peng D; Hao H
    Antibiotics (Basel); 2022 Feb; 11(2):. PubMed ID: 35203885
    [No Abstract]   [Full Text] [Related]  

  • 6. Ex vivo pharmacokinetic/pharmacodynamic relationship of valnemulin against Clostridium perfringens in plasma, the small intestinal and caecal contents of rabbits.
    Zhou YF; Yu Y; Sun J; Tao MT; Zhou WJ; Li X; Liao XP; Liu YH
    Anaerobe; 2016 Jun; 39():150-7. PubMed ID: 27060276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic-Pharmacodynamic Modeling of Enrofloxacin Against Escherichia coli in Broilers.
    Sang K; Hao H; Huang L; Wang X; Yuan Z
    Front Vet Sci; 2015; 2():80. PubMed ID: 26779495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of pharmacokinetic-pharmacodynamic for dose optimization of doxycycline against Haemophilus parasuis in pigs.
    Zhang L; Li Y; Wang Y; Sajid A; Ahmed S; Li X
    J Vet Pharmacol Ther; 2018 Oct; 41(5):706-718. PubMed ID: 29696661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial activity of combined aditoprim and sulfamethoxazole against Escherichia coli from swine and a dose regimen based on pharmacokinetic-pharmacodynamic modeling.
    Wang F; Luo W; Pan Y; Qu W; Xie S; Huang L; Wang Y
    J Vet Pharmacol Ther; 2022 Jan; 45(1):133-145. PubMed ID: 34435681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistant cutoff values and optimal scheme establishments for florfenicol against Escherichia coli with PK-PD modeling analysis in pigs.
    Lei Z; Liu Q; Khaliq H; Cao J; He Q
    J Vet Pharmacol Ther; 2019 May; 42(3):324-335. PubMed ID: 30801741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of a dosage regimen of colistin by pharmacokinetic/pharmacodynamic integration and modeling for treatment of G.I.T. disease in pigs.
    Guyonnet J; Manco B; Baduel L; Kaltsatos V; Aliabadi MH; Lees P
    Res Vet Sci; 2010 Apr; 88(2):307-14. PubMed ID: 19945722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal Regimens and Clinical Breakpoint of Avilamycin Against
    Huang A; Luo X; Xu Z; Huang L; Wang X; Xie S; Pan Y; Fang S; Liu Z; Yuan Z; Hao H
    Front Pharmacol; 2022; 13():769539. PubMed ID: 35281904
    [No Abstract]   [Full Text] [Related]  

  • 13. The dose regimen formulation of tilmicosin against Lawsonia intracellularis in pigs by pharmacokinetic-pharmacodynamic (PK-PD) model.
    Luo W; Qin H; Chen D; Wu M; Meng K; Zhang A; Pan Y; Qu W; Xie S
    Microb Pathog; 2020 Oct; 147():104389. PubMed ID: 32707311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal regimens based on PK/PD cutoff evaluation of ceftiofur against Actinobacillus pleuropneumoniae in swine.
    Sun D; Mi K; Hao H; Xie S; Chen D; Huang L
    BMC Vet Res; 2020 Sep; 16(1):366. PubMed ID: 32993661
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Zhang W; Lu Y; Ma M; Yang J; Huang H; Peng X; Zeng Z; Zeng D
    Front Vet Sci; 2024; 11():1362292. PubMed ID: 38756506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of valnemulin susceptibility breakpoint against Clostridium perfringens in rabbits.
    Tao MT; Zhou YF; Sun J; Liu YH; Liao XP
    Anaerobe; 2017 Dec; 48():118-120. PubMed ID: 28801120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug resistance in Clostridium perfringens isolated from diarrheal neonatal piglets in Thailand.
    Ngamwongsatit B; Tanomsridachchai W; Suthienkul O; Urairong S; Navasakuljinda W; Janvilisri T
    Anaerobe; 2016 Apr; 38():88-93. PubMed ID: 26752714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation of a rational dosage regimen of ceftiofur hydrochloride oily suspension by pharmacokinetic-pharmacodynamic (PK-PD) model for treatment of swine
    Luo W; Wang D; Qin H; Chen D; Pan Y; Qu W; Huang L; Xie S
    J Vet Sci; 2021 Nov; 22(6):e41. PubMed ID: 34854264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of isopropoxy benzene guanidine against
    Lu Y; Yang L; Zhang W; Li J; Peng X; Qin Z; Zeng Z; Zeng D
    Front Vet Sci; 2022; 9():1004248. PubMed ID: 36246309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of a clinical Escherichia coli strain to repeated cefquinome exposure in a piglet tissue-cage model.
    Gu M; Zhang N; Zhang L; Xiong M; Yang Y; Gu X; Shen X; Ding H
    BMC Vet Res; 2015 Jul; 11():169. PubMed ID: 26209108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.